Introduction
Post-translational short-term regulations of plasma membrane transporters adapt transporter activities according to physiological demands (Zhang et al., 2008; Kock et al., 2010; Vina-Vilaseca et al., 2011; Gorboulev et al., 2012; Leto and Saltiel, 2012; Mühlfeld et al., 2012; Zhang et al., 2013) .
Physiologically important examples are insulin-induced recruitment of glucose transporter GLUT4 to the plasma membrane of adipocytes (Leto and Saltiel, 2012) , protein kinase C dependent endocytosis of organic anion transporter OAT1 (Zhang et al., 2008; Zhang et al., 2013) , and glucose-induced incorporation of the Na + -D-glucose cotransporter SGLT1 into brush-border membranes of small intestinal enterocytes (Gorboulev et al., 2012) . Recently we observed that regulation of the release of SGLT1 containing vesicles from the trans-Golgi network (TGN) contributes to short-term regulation of SGLT1 (Kroiss et al., 2006; Veyhl et al., 2006) .
Human RS1 (hRS1) is encoded by the intronless single copy gene RSC1A1. This gene first appeared in mammals and encodes 67-68 kDa proteins with about 70% amino acid identity between species (Reinhardt et al., 1999; Veyhl et al., 1993; Lambotte et al., 1996; Osswald et al., 2005) . RS1 is expressed in various tissues and cell types (Valentin et al., 2000; Korn et al., 2001; Osswald et al., 2005) . In the renal epithelial cell line LLC-PK 1 RS1 protein was detected at the TGN, within the nucleus, and at the plasma membrane (Kroiss et al., 2006) . At the TGN RS1 was colocalized with SGLT1 (Kroiss et al., 2006) . Evidence has been provided that RS1 participates in transcriptional and post-translational regulations of SGLT1. For example we showed that RS1 is involved in the transcriptional upregulation of SGLT1 during confluence of LLC-PK 1 cells (Korn et al., 2001 ). We identified a nuclear shuttling domain in the center of RS1 that steers nuclear migration of RS1 during confluence of LLC-PK 1 cells and observed that a COOH-terminal fragment of hRS1 is involved in the regulation of transcription (Filatova et al., 2009) . So far transcriptional regulation by RS1 has not been investigated in detail.
Expressing SGLT1 in oocytes of Xenopus laevis and injecting RS1 protein or a peptide motif of RS1, we characterized short-term post-translational effects on the abundance of SGLT1 in the plasma membrane (Veyhl et al., 2006; Vernaleken et al., 2007) . We observed that short-term downregulation of hSGLT1 after injection of hRS1 protein was abolished when the Golgi was dissociated with This article has not been copyedited and formatted. The final version may differ from this version. brefeldin A (BFA) or when vesicle fusion with the plasma membrane was blocked with botulinum toxin B (BTXB) but was not influenced by inhibitors of endocytosis (Veyhl et al., 2006) . The exocytotic pathway of hSGLT1 expressed in oocytes was also blocked after injection of nanomolar concentrations of the tripeptide motif Gln-Ser-Pro (QSP) in hRS1 (Vernaleken et al., 2007) . The high affinitiy of QSP for downregulation of hSGLT1 suggests that QSP, and probably also hRS1, bind to an intracellular high-affinity receptor protein that mediates downregulation. Noteworthy we observed that the short-term downregulation of hSGLT1 by hRS1 or QSP was blunted after cellular injection of Dglucose or the non-metabolized glucose analogues 2-deoxyglucose (2-DOG) or α -methylglucoside (AMG) (Veyhl et al., 2006; Vernaleken et al., 2007) . Because QSP is too small to form a glucose binding site, the glucose binding site mediating glucose dependence of QSP mediated downregulation may be located at the receptor protein for RS1 or at a protein that is associated with the receptor protein.
Recently we observed that hRS1 also downregulates the exocytotic pathway(s) of the human concentrative nucleoside transporters hCNT1, hCNT2, and hCNT3 (Errasti-Murugarren et al., 2012) .
The aim of our present study was to find out whether hRS1 blocks a common exocytotic pathway for hSGLT1 and hCNT1 or whether different exocytotic pathways for SGLT1 and CNT1 exist that are addressed separately. We identified an NH 2 -terminal domain of hRS1 named hRS1-Reg that contains two QSP motifs within predicted phosphorylation sites, many additional predicted phosphorylation sites, and predicted binding sites for regulatory proteins. We showed that dependent on phosphorylation of hRS1-Reg either hSGLT1 was downregulated in a glucose dependent manner or hCNT1 was downregulated independently of glucose. Performing studies with RS1 knockout mice (Osswald et al., 2005) and wildtype mice we provided evidence that glucose dependent disinhibition of RS1-induced post-translational downregulation of SGLT1 in small intestine is responsible for upregulation of SGLT1 after glucose-rich meals.
Materials and Methods
Animals. C57BL/6 wildtype mice and Rs1 -/-mice on C57BL/6 background (Osswald et al., 2005) were kept in temperature controlled environment with 12 hours light cycle. The mice were provided This article has not been copyedited and formatted. The final version may differ from this version. (Torchilin, 2008) was delivered by Peptides International (Louisville, Kentucky, USA). Other chemicals were purchased as described (Pipkorn et al., 2002; Keller et al., 2005; Vernaleken et al., 2007) .
Preparation of Nanohydrogels with Coupled Peptides. Nanohydrogels (NGs) were prepared from inversed miniemulsions as described (Groll et al., 2009) . Inversed miniemulsions were prepared from 2.5 ml of hexane containing 50.3 mg Span 80 and 16.7 mg Tween 80, and 0.4 ml of 20 mM Hepes pH 7.4 containing 100 mg thiol-functionalized linear poly(glycidol) polymer (Groll et al., 2009) Oxidation was quenched by acidification and the NGs were separated by centrifugation. The aqueous layers containing the NGs were separated and washed four times with a tetrahydrofuran/water (20%/80%)-mixture to remove surfactants and unreacted polymer. Remaining organic solvents and acid were removed by dialysis against water. The suspensions containing 50 mg/ml NGs loaded with 0.225 mg mRS1-Reg polypeptides, were stored up to two weeks at 4°C.
Cloning. For coexpression with hSGLT1 in oocytes, hRS1 cDNA variants coding for the hRS1 fragments shown in Fig. 1 were generated on basis of wildtype hRS1 in vector pRSSP (pRSSP/hRS1) (Busch et al., 1996) . They were cloned into ApaI and XhoI sites of pRSSP. To synthesize variants This article has not been copyedited and formatted. The final version may differ from this version. coding for amino acids 1-251, 1-183, 1-140, 1-111 of hRS1, PCR was performed using pRSSP plasmid-specific forward primer and reverse primers at the corresponding positions of hRS1 which contained a stop codon and XhoI restriction site. The amplificates were digested with ApaI and XhoI and inserted into the pRSSP vector. To prepare cDNA variants coding for hRS1 fragments 50-183, 20-50, 30-50, and 30-40 , PCR was performed with hRS1 derived forward primers containing the ApaI adaptor and the initiation codon. The hRS1-derived reverse primers contained the XhoI adaptor.
Amplificates were digested with ApaI and XhoI and inserted into pRSSP vector.
At the beginning of the study oocyte experiments with injected peptides were performed with glutathion-S-transferase (GST) fusion proteins of hRS1-Reg and of hRS1-Reg mutants (hRS1-Reg(S45A), hRS1-Reg(S45E), hRS1-Reg(S83A), hRS1-Reg(S83E)). The peptides were linked to the C-terminus of GST using the vector pGEX5X-3 (GE Healthcare Europe GmbH, Freiburg, Germany)
for expression in E. coli. Later experiments were performed with uncoupled hRS1-Reg, hRS1-Reg mutants (hRS1-Reg(S20A), hRS1-Reg(S20E)), mRS1-Reg, and mRS1-Reg mutants (mRS1-Reg(S19A), mRS1-Reg(S19E)) expressed in vector pET21a. The uncoupled variants contained an NH 2 -terminal cysteine which was used for coupling to NGs.
hRS1 (Lambotte et al., 1996) and mRS1 (GenBank accession number Y11917) were used as templates to synthesize hRS1-Reg comprising amino acids Ser16-Gln98 of hRS1 and mRS1-Reg comprising Pro15-His92 of mRS1-Reg by PCR (Fig. 3 ). Mutants were generated by applying the PCR overlap extension method (Ho et al., 1989) .
For expression of GST fusion proteins, PCR of hRS1-Reg, hRS1-Reg(S45A), hRS1-Reg(S45E), hRS1-Reg(S83A), and hRS1-Reg(S83E) was performed using hRS1 derived primers containing BamHI and SalI sites. The amplification products were cut with BamHI and SalI and cloned into the vector pGEX5X-3 in the open reading frame with the N-terminal GST.
For expression of uncoupled hRS1-Reg, hRS1-Reg mutants (hRS1-Reg(S20A), hRS1-Reg(S20E)) PCR was performed using the forward primer 5' TATACATATGTG-CTCTTCAGGACAGAGTCCTG 3' and the reverse primer 5' GTCTCGAGCTGCATA-GGCATAGCTGG 3'. For expression of uncoupled mRS1-Reg, mRS1-Reg(S19A) and mRS1-Reg(S19E) the forward primer 5' GGTACATATGTGTCCTTCAGGGCAGAGTCCTG 3' and the This article has not been copyedited and formatted. The final version may differ from this version. Technologies, Darmstadt, Germany) were transfected with pGEX5X-3 plasmids and grown to 50% maximal density. After induction by 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) bacteria were grown for 3 h at 30 o C, pelleted by 15 min centrifugation at 6,000 × g, washed, and suspended in 20 mM Hepes, pH 7.5 containing 150 mM NaCl. Bacteria were lysed by sonication at 4 o C, and cellular debris was removed by 1 h centrifugation at 100,000 × g. For protein purification 0.5 ml of
Glutathione-Sepharose (GE-Healthcare, Munich, Germany) was added to 10 ml lysate and incubated for 1 h at 4 o C. The suspension was poured into an empty gravity flow column, washed with 25 ml of 20 mM Hepes, pH 7.5 containing 150 mM NaCl, and the GST-fusion proteins were eluted with 2.5 ml of 20 mM Hepes, pH 7.5 containing 150 mM NaCl and 20 mM glutathione. Fractions containing purified protein were pooled and dialyzed against K-Ori buffer (5 mM MOPS, pH 7.4, 103 mM KCl, 1 mM MgCl 2 ).
Expression and Purification of Uncoupled hRS1-Reg, mRS1-Reg and Mutants. E. coli bacteria (strain BL21) were transformed with pET21a plasmids containing His-tagged hRS1-Reg or mRS1-Reg and grown to mid-log phase. Protein expression was induced by IPTG and bacteria were grown for 3 h at 30°C. After 15 min centrifugation at 6,000 × g, bacteria were washed, suspended in 20 mM
Tris-HCl pH 8.0 containing 500 mM NaCl and 50 mM imidazole, lysed by sonication at 4°C, and cellular debris was removed by 1 h centrifugation at 100,000 × g. For protein purification the supernatants were mixed with Ni 2+ -NTA-Agarose (Qiagen, Hilden, Germany), incubated for 1 h under rotation, and poured into an empty gravity flow column. After extensive washing with 20 mM TrisHCl, pH 8.0 containing 500 mM NaCl and 50 mM imidazole, protein was eluted with the same buffer containing 500 mM imidazole. Fractions containing purified protein were pooled and dialyzed against This article has not been copyedited and formatted. The final version may differ from this version. cRNA Synthesis. For cRNA synthesis human SGLT1 (hSGLT1) in pBSII SK (Hediger and Rhoads, 1994) , human hCNT1 (hCNT1) in vector pBSII KS (Errasti-Murugarren et al., 2012) , human RS1 (hRS1) in vector pRSSP (Busch et al., 1996) , and hRS1-fragments in pRSSP were used. To prepare sense cRNAs the respective purified plasmids were linearized with EcoRI (hSGLT1), MluI (hRS1) or XbaI (hCNT1). m 7 G(5´)G-capped sense cRNAs were synthesized using T3 polymerase (hSGLT1, hCNT1) or SP6 polymerase (fragments of hRS1). cRNAs were prepared employing the "mMESSAGE mMachine" kit (Ambion Life Technologies) using sodium acetate precipitation. cRNA concentrations were estimated from ethidium bromide-stained agarose gels using polynucleotide marker as standards (Gründemann and Koepsell, 1994) . the jejunal segments were dissolved in 0.5 ml Soluene-350®. Radioactivity was analyzed by liquid scintillation counting. Phlorizin inhibited AMG uptake and Na + dependent uridine uptake per cm length were calculated using four 1 cm-segments per experimental condition.
Expression of Transporters and hRS1-fragments in
Preparation of Brush-border Membrane Vesicles from Small Intestine. Brush-border membrane (BBM) vesicles were isolated by magnesium precipitation followed by differential centrifugation.
Small intestines of three mice were homogenized at 0 o C in 35 ml 2 mM Hepes/Tris, pH 7.1, containing 100 mM mannitol. 1 M MgCl 2 solution was added to a concentration of 10 mM, and the suspension was kept on ice for 20 min and centrifuged for 15 min at 3,000 × g. The pellet containing nuclei and mitochondria was discarded and the supernatant was centrifuged for 30 min at 27 000 × g.
The resulting pellet was suspended in 35 ml vesicle buffer (20 mM Hepes/Tris, pH 7.4, 100 mM mannitol) and centrifuged for 30 min at 27,000 × g. The obtained pellet containing the BBM vesicles was suspended in 0.3 ml vesicle buffer, snap-frozen in liquid nitrogen and stored at -70 o C until use. In the isolated BBM vesicles the activity of alkaline phosphatase was enriched 12 + 2 (SD, n=10) compared to the homogenates. In BBM vesicles prepared from Rs1 -/-vesicles the same enrichment of alkaline phosphatase activity was obtained.
Measurement of SGLT1 Mediated AMG Uptake into BBM Vesicles. BBM vesicles were thawed in a water bath and phlorizin-inhibitable uptake of AMG was measured at 22 o C using the rapid filtration technique (Hopfer et al., 1973) . BBM vesicles were incubated 10 sec with vesicle buffer containing 0.1 mM AMG traced with [ 14 C]AMG plus either 100 mM NaSCN or 100 mM NaSCN and 0.2 mM phlorizin. Uptake was stopped with ice-cold vesicle buffer which contained 0.2 mM phlorizin.
The vesicles were washed on nitrocellulose filters using the same solution. The radioactivity on the filters was measured and phlorizin inhibitable uptake was calculated.
MOL #101162
Estimation of SGLT1 and GLUT2 Protein in BBM Vesicles. BBM vesicles were separated by SDS polyacrylamide electrophoresis, transferred to polyvinylidene difluoride membrane, and probed with antibody against mouse SGLT1 or antibody against human GLUT2 that cross-reacts with mouse GLUT2 (Gorboulev et al., 2012) . Quantification of immunostaining was performed by densitometry (Gorboulev et al., 2012) .
Statistics. Uptake measurements indicated in the graphs are presented as mean + SE. In experiments with oocytes, each mean value was calculated from uptake measurements in 16-27 individual transporter expressing oocytes from 2 or 3 independent experiments which were corrected for uptake Uptake rates of phlorizin inhibited AMG uptake into BBM vesicles were calculated from 3 independent experiments. In each experiment 3 uptake measurements were performed in the absence of phlorizin and corrected for uptake measured in the presence of phlorizin. Uptake rates measured in intestinal mucosa were calculated from measurements in 4-7 animals. For each animal the uptake rate was calculated from 8 measurements using 2 experimental conditions (AMG uptake without and with phlorizin, uridine uptake in the presence and absence of sodium). When three or more groups of data were compared, significance of differences was determined by ANOVA using posthoc Tukey comparison. Significance of differences of two groups was determined by Student´s t test. p<0.05 was considered significant.
Results
Identification of a hRS1 Domain that Blocks the Exocytotic Pathway of hSGLT1. Previously we described that injection of 0.1 µM QSP into hSGLT1 expressing X. laevis oocytes induced a downregulation of hSGLT1 mediated glucose uptake by about 40% (Vernaleken et al., 2007) .
Performing coexpression of hSGLT1 with various NH 2 -terminal hRS1-cRNA fragments in Xenopus
This article has not been copyedited and formatted. The final version may differ from this version. laevis oocytes we observed that a cRNA fragment encoding the amino acids IKPSDSDRIEP decreased hSGLT1 expressed uptake of 50 µM AMG to a similar degree as QSP (Fig. 1 ). To further define and functionaly characterize the active peptide motif we performed short-term inhibition experiments with IKPSDSDRIEP and fragments of this peptide (Fig. 2) . We expressed hSGLT1 in oocytes by cRNA injection and incubation for two days, injected peptides, and measured expressed uptake of 50 µM AMG 1 h later. Because we had determined previously that injection of RS1 protein and QSP into hSGLT1
expressing oocytes decreased the amount of SGLT1 in the plasma membrane without altering uptake kinetics of AMG (Veyhl et al., 2006; Vernaleken et al., 2007) , the observed changes in AMG uptake were interpreted to indicate changes of hSGLT1 abundance in the plasma membrane. Fig. 2A shows that also the octapeptide SDSDRIEP and the tetrapeptide SDSD downregulate hSGLT1. However, the affinity of SDSDRIEP was more than 500fold higher compared to SDSD ( hRS1-Reg contains 16 serine residues and one threonine residue. For all these residues phosphorylation is predicted (program GPS version 2.1 http://gps.biocuckoo.org). In hRS1-Reg five binding motifs for Src homology (SH) proteins and two binding motifs for protein 14-3-3 are also predicted (program Minimotif miner http://mnm.engr.uconn.edu/MNM/SMSSearchServlet).
This article has not been copyedited and formatted. The final version may differ from this version. The characteristics of hRS1-Reg were similar to QSP and SDSDRIEP. When hRS1-Reg was injected into oocytes expressing hSGLT1, AMG uptake was downregulated to the same level as after injection of BFA (Fig. 4A ). Downregulation by BFA and hRS1-Reg were not additive (Fig. 4A) . The EC 50 for downregulation by hRS1-Reg (68 + 3.7 nM, mean + SD from 3 experiments) (Fig. 4B ) was much higher compared to QSP (0.17 + 0.03 nM, mean + SD from 3 experiments, p<0.001 for difference) (Supplemntal Fig. 1A ) and SDSDRIEP (4.7 + 0.4 nM, mean + SD from 3 experiments, p<0.001 for difference to hRS1-Reg) (Fig. 2B) . After injection of 100 pmol AMG, the EC 50 for inhibition of AMG uptake by hRS1-Reg was increased from 68 + 3.7 nM to 540 + 5.0 nM (means + SD from 3 experiments) (p<0.001 for difference) (Fig. 4B ). The data suggest that QSP and SDSDRIEP are binding motifs within hRS1-Reg that binds to a receptor protein associated with the TGN. We named this proposed protein R (SGLT1) . R (SGLT1) is supposed to modulate the release of hSGLT1 containing vesicles in a glucose dependent way.
hRS1-Reg Phosphorylation by PKC or Calmodulin Kinase 2 Changes Affinity for
Downregulation of hSGLT1. We determined the affinity of hRS1-Reg for downregulation of hSGLT1 mediated AMG uptake after stimulation of PKC with phorbol-12-myristate-13-acetate (PMA), after inhibition of PKC with calphostin C, and after inhibition of Calmodulin kinase 2 (CamK2) with KN93 ( Fig. 5 ,A,B and D). The EC 50 for downregulation by hRS1-Reg was not changed by calphostin C but decreased by PMA from 68 + 3.7 nM to 5.1 + 0.3 nM (means + SD from 3 experiments, p<0.001 for difference) (Fig. 5A ). The higher degree of maximal downregulation observed in the presence of PMA suggests an additional PMA effect on hSGLT1 expression. KN93
decreased the EC 50 for inhibition of hRS1-Reg for downregulation of hSGLT1 dramatically from 68 + 3.7 nM to 112 + 4.3 fM (means + SD from 3 experiments, p<0.001 for difference) (Fig. 5B) . We investigated whether phosphorylation of the predicted PKC dependent phosphorylation site at serine 45 in the SDSDRIEP motif is critical for the PMA effect on affinity. After blocking phosphorylation by alanine replacement (hRS1-Reg(S45A)) the affinity was not changed significantly (Figs. 5,C and E). However, after mimicking phosphorylation by replacement with glutamate (hRS1-Reg(S45E)) the EC 50 for inhibition was decreased to the same level as with hRS1-Reg in the presence of PMA (4.5 + This article has not been copyedited and formatted. The final version may differ from this version. 1.9 nM compared to 5.1 + 0.3 nM, means + SD from 3 experiments) (Fig. 5C ). The data indicate that PKC increases the affinity of hRS1-Reg for downregulation of hSGLT1 by phosphorylation of Ser45.
CamK2 dependent phosphorylation is predicted for Ser20, Ser34 and Ser83 of human RS1 (Fig. 3 ).
When we prevented phosphorylation at Ser83 by replacement with alanine (hRS1-Reg(S83A)) we obtained a similar EC 50 value for downregulation of hSGLT1 mediated AMG uptake as with hRS1-Reg in the presence of KN93 (93 + 5.7 fM versus 112 + 4.3 fM, means + SD from 3 experiments) (Fig.   5B ). After exchange of Ser83 by glutamate (hRS1-Reg(S83E)) the EC 50 value was similar to hRS1-Reg without inhibition of CamK2 (55 + 0.23 nM compared to 68 + 3.7 nM, means + SD from 3 experiments) (Fig. 5B) . The data suggest that in oocytes hRS1-Reg is phosphorylated at serine 83, and that the affinity-increase observed after blockage of CamK2 is mainly due to dephosphorylated Ser83.
Next we investigated whether the AMG induced affinity-decrease of hRS1-Reg is influenced by PKC or CamK2 dependent phosphorylation. After injection of 100 pmol AMG a similar decrease of hRS1-Reg affinity was observed in absence and presence of calphostin C (Fig. 5D ). Noteworthy the drastical decrease of EC 50 for downregulation of hRS1-Reg by KN93 was reversed after injection of 100 pmol AMG (112 + 4.3 fM versus 117 + 44 nM) (means + SD from 3 experiments, p<0.001 for difference) (Fig. 5D ). Wondering whether AMG dependent phosphorylation of Ser83 causes the AMG induced affinity decrease, we determined the effect of AMG on the affinity of hRS1-Reg(S83A). After injection of 100 pmol AMG into oocytes the EC 50 of hRS1-Reg(S83A) for downregulation of hSGLT1 was increased from 93 + 5.7 fM to 455 + 74 nM (means + SD from 3 experiments, p<0.001 for difference) (Fig. 5E ). This excludes that AMG dependent affinity-decrease is mediated via phosphorylation of Ser83.
Mimicking Phosphorylation of Ser in the NH 2 -terminal QSP motif of hRS1-Reg or mRS1-Reg
Increases Affinity for Downregulation of SGLT1 at High Intracelluar Glucose. The NH 2 -terminal QSP in RS1-Reg is conserved between human and mouse (Fig. 3) . In both species phosphorylation of this serine is predicted by MAP kinases 1, 9, 10, 14 and cyclin dependent kinase 5. Mass spectrometry of purified hRS1 protein that had been overexpressed in Sf9 insect cells revealed that serine in the NH 2 -terminal QSP (Ser20) was phosphorylated (A. Friedrich, C. Otto, P. Reddy Rikkala, M. whether the affinity for downregulation of hSGLT1 by hRS1-Reg was altered when Ser20 in hRS1-Reg was exchanged by alanine (hRS1-Reg(S20A)) or glutamate ((hRS1-Reg(S20E)) (Fig. 6,A and E) .
The EC 50 of hRS1-Reg(S20A) for downregulation of hSGLT1 was similar to hRS1-Reg suggesting that Ser20 of hRS1-Reg is not phosphorylated in the oocytes. In contrast, the EC 50 of hRS1-Reg(S20E) was much lower compared to hRS1-Reg (19 + 0.23 pM versus 68 + 3.7 nM, means + SD fro 3 experiments, p<0.001 for difference). After injection of 100 pmol AMG the EC 50 of hRS1-Reg(S20A) was increased from 48 + 7.7 nM to 338 + 19 nM, means + SD from 2 and 3 experiments, p<0.001 for difference) (Fig.6,B and E) . Surprisingly, the EC 50 of hRS1-Reg(S20E) was decreased after injection of AMG (19 + 0.23 pM versus 33 + 1.0 fM, means + SD from 3 experiments, p<0.01 for difference) (Fig. 6 ,B and E).
Planning experiments in mice using murine RS1-Reg (mRS1-Reg) we determined the effects of serine replacement in the QSP motif of mRS1-Reg. For downregulation of hSGLT1 expressed AMG uptake in oocytes by mRS1-Reg(S19A) and mRS1-Reg(S19E) respective EC 50 values of 8.5 + 2.4 nM and 2.0 + 1.4 pM were obtained (means + SD from 2 or 3 experiments, p<0.01 for difference) ( of hCNT1 mediated uridine uptake (oocytes without AMG injection) a higher EC 50 value was obtained compared to hSGLT1 mediated AMG uptake (Fig. 7A ) (125 + 13 nM versus 68 + 3.7 nM, means + SD of 3 experiments, p<0.01 for difference). Noteworthy hCNT1 mediated uridine uptake was downregulated by SDSDRIEP but not by QSP (Fig. 7B) , and the EC 50 for downregulation of hCNT1 by SDSDRIEP was much higher compared to the EC 50 for downregulation of hSGLT1 by SDSDRIEP This article has not been copyedited and formatted. The final version may differ from this version. at the TGN occur via independent exocytotic pathways. This suggests that different receptor proteins for hRS1 are involved, a glucose dependent receptor protein addressing hSGLT1 (R (SGLT1) ) and a glucose independent receptor protein addressing hCNT1 which we named R (CNT1) . nM, hRS1-Reg(S45E) 173 + 18 nM; means + SD from 3 experiments, p<0.001 for difference between hRS1-Reg(S45A) and hRS1-Reg) (Fig. 7,D and G) . The data suggest that PKC dependent phosphorylation of Ser45 is involved in navigating downregulation of hSGLT1 versus hCNT1.
RS1-Reg Phosphorylation Determines
When Ser83 in hRS1-Reg was replaced by alanine or glutamate, the affinity for downregulation of hCNT1 mediated uridine uptake was not altered significantly (Fig. 7, E and G) . This is at variance to regulation of hSGLT1 where the affinity of hRS1-Reg(S83A) was much higher compared to hRS1Reg(S83E) (Fig. 5,B and E) .
Different effects on affinity for downregulation of hSGLT1 versus hCNT1 were also observed after mimicking or preventing phosphorylation of Ser20 in hRS1-Reg. Whereas the EC 50 of hRS1-Reg(S20E) for downregulation of hCNT1 was 39% lower than hRS1-Reg wildtype (77 + 16 nM versus 125 + 13 nM, means + SD of 3 experiments, p<0.01 for difference) (Fig. 7,F and G) , the EC 50 value for downregulation of hCNT1 by hRS1-Reg(S20A) was more than three orders of magnitude This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 7,F and G) . At variance, the EC 50 value for downregulation of hSGLT1 by hRS1-Reg(S20E) was more than three orders of magnitude lower compared to hRS1-Reg wildtype whereas the IC 50 for downregulation of hSGLT1 by hRS1-Reg(S20A) was similar to hRS1-Reg (Fig. 6,A and E ). Similar differences were observed for mutations in the QSP motif of mRS1-Reg. The EC 50 for downregulation of hCNT1 mediated uridine uptake by mRS1-Reg(S19A) was more than two orders of magnitude lower compared to mRS1-Reg(S19E) (53 + 2.9 pM versus 122 + 1.0 nM, means + SD of 2 experiments, p<0.001 for difference) (Fig. 7G) . At variance, the EC 50 for downregulation of hSGLT1 mediated AMG uptake by mRS1-Reg(S19A) was more than two orders of magnitude higher compared to mRS1-Reg(S19E) (8.5 + 2.4 nM and 2.0 + 1.4 pM, means + SD of 3 experiments, p<0.01 for difference) (Fig. 6 ,C and E).
Involvement of RS1 in Upregulation of Glucose Absorption in Small Intestine after a Glucoserich Meal. Previously we showed that SGLT1 in the brush-border membrane (BBM) of enterocytes is
rate-limiting for small intestinal glucose absorption (Gorboulev et al., 2012) . We also reported that SGLT1 in the BBM of murine small intestine was upregulated after gavage with glucose. To determine whether RS1 is involved in this glucose dependent upregulation of SGLT1, we gavaged male wildtype mice and Rs1 -/-mice with D-glucose, sacrificed the animals 30 min later, and isolated BBM vesicles from jejunum. We measured phlorizin-inhibited AMG uptake into the BBM vesicles ( Fig. 8A ) and quantified SGLT1 (Fig. 8B ) and facilitative glucose transporter 2 (GLUT2) (Fig. 8C ) in the BBM in immunostained Western blots. In jejunum of Rs1 -/-mice the protein amount and transport activity of SGLT1 in the BBM were similar as in wildtype mice after gavage with glucose.
Noteworthy, in Rs1 -/-mice no increase of SGLT1 amount and activity in the BBM was observed after gavage with D-glucose (Fig. 8,A and B) . After gavage of wildtype mice with D-glucose some upregulation of GLUT2 in the BBM was observed as described earlier (Gouyon et al., 2003; Gorboulev et al., 2012) (Fig. 8C) . In Rs1 -/-mice the amount of GLUT2 in the BBM and upregulation of GLUT2 after gavage with D-glucose were similar as in wildtype mice (Fig. 8C) . To estimate the velocity of the RS1 dependent glucose-induced upregulation of SGLT1 in the BBM we incubated everted jejunum of wildtype and Rs1 -/-mice for 2 min without and with 2 mM AMG, and isolated This article has not been copyedited and formatted. The final version may differ from this version. protein in the BBM after immunostaining (Fig. 8,D and E) . Similar results were obtained as after glucose gavage indicating that the glucose dependent upregulation of SGLT1 occurs within 2 min. The data indicate that RS1 is critically involved in glucose dependent upregulation of SGLT1 in small intestine. We suggest the mechanism depicted in Fig. 9 , A and B.
Differential Downregulation of AMG and Uridine Uptake by RS1-Reg Mutants in Murine
Small Intestine. We investigated whether selective downregulation of exocytotic pathways of hSGLT1 versus hCNT1 by RS1-Reg mutants can be demonstrated in mouse small intestine. The effects of mRS1-Reg(S19A) and mRS1-Reg(S19E) on phlorizin inhibited AMG uptake and on sodium dependent uridine uptake into enterocytes were measured. To protect the peptides from enzymatic degradation and to allow peptide entrance into the mucus, we coupled the mRS1-Reg mutants via disulfide linkage into biocompatible nanohydrogel (NG) (Singh et al., 2013) . The employed NG is a colloidal hydrophilic polymer network which is cross-linked by disulfides and additionally modified by the cell penetrating peptide TAT (Torchilin, 2008) . Under acidic conditions such as in stomach, the NG is stable and the enclosed peptides are sterically protected from degradation. In basic mileu like in intestine, the NG becomes mucoadhesive due to OH -induced disulphide shuffling with the mucus layer (Bernkop-Schnurch, 2005) facilitating contact of NG and bound peptides with the plasma membrane of the enterocytes. To compare effects of the mRS1-Reg mutants on AMG uptake versus uridine uptake, we used Rs1 -/-mice to avoid interference of regulation by endogenous RS1 (Fig. 10,A and B). Mice were gavaged with 200 µl empty NG (control) or NG loaded with 1 nmol mRS1-Reg mutant. Three hours after gavage, phlorizin inhibited uptake of 10 µM AMG or sodium dependent uptake of 1 µM uridine was measured. Uptake of 10 µM AMG was not altered after gavage with mRS1-Reg(S19A) but down-regulated by 21% (P<0.01) after gavage with mRS1-Reg(S19E) (Fig.   10A ). At variance uptake of 1 µM uridine was downregulated 22% (p<0.01) by mRS1-Reg(S19A)
whereas it was not altered by mRS1-Reg(S19E) (Fig. 10B) . The data suggest that phosphorylation of RS1-Reg induces differential regulation of SGLT1 versus CNT1 in small intestine. Measuring phlorizin inhibited uptake of 1 mM AMG after gavage of mRS1 -/-mice with NG loaded with mRS1-20 MOL #101162 intracellular AMG concentration during uptake of 1 mM AMG does not blunt downregulation by mRS1-Reg(S19E).
We also investigated the effect of mRS1-Reg(S19E) on phlorizin inhibited uptake of 10 µM and 1 mM AMG into enterocytes of wildtype mice (Fig. 10,D and E) . Due to downregulation of mSGLT1 in the BBM by endogeneous mRS1 at low intracellular glucose no further inhibitory effect on the uptake of 10 µM AMG was observed (Fig. 10D) . However, because downregulation via endogenous mRS1 is blunted at high intracellular glucose (Fig. 9B) , uptake of 1 mM AMG uptake was down-regulated by mRS1-Reg(S19E) (p<0.001) (Fig. 9C, Fig. 10E ).
Discussion
We describe that an NH 2 -terminal domain of regulatory protein RS1 ( We demonstrated different effects of RS1-Reg phosphorylation on regulation of two transporters.
However, the more general interpretation that exocytotic pathways of various plasma membrane transporters are addressed by different regulatory states of RS1-Reg, is viewed to be warranted for several reasons. First, we observed that RS1 mediates post-translational downregulation of most transporters that have been tested in addition to hSGLT1 and hCNT1. Post-translational downregulation by RS1 was observed for human Na + -nucleoside cotransporters CNT1, CNT2, and CNT3 (ErrastiThis article has not been copyedited and formatted. The final version may differ from this version. Murugarren et al., 2012) , for organic cation transporter OCT1 from rat (Veyhl et al., 2003) , and for OCT2 from rat and human (Reinhardt et al., 1999; Veyhl et al., 2003; Veyhl et al., 2006) . Second, RS1-Reg contains many predicted phosphorylation sites and binding sites for regulatory proteins thus suggesting a large diversity of modifications. Third, at variance to downregulation of hSGLT1 which was blunted by high intracellular glucose, the downregulation of hOCT2 by hRS1 was only observed in the presence of high intracellular glucose (Veyhl et al., 2006) .
We provided in vivo evidence for differential regulation of endogenously expressed SGLT1 and CNT1 in mouse small intestine. To exclude regulation by endogenous RS1 some of these experiments were performed in Rs1 -/-mice. We tested the effects of mRS1-Reg mutants preventing or mimicking phosphorylation of serine in the conserved QSP motif. To introduce the mutants into enterocytes we gavaged mice with nanohydrogel (NG) containing mRS1-Reg mutants coupled by disulfide linkage.
Our data indicate that the NG represents an effective delivery system; however, mechanistic details remain to be resolved. It must be clarified whether the NG is dissociated within the glycocalix covering the enterocytes and whether released peptides or NG fragments bearing the peptides enter the cells by endocytosis. In addition, it has to be determined how the peptides leave the endocytotic compartment. The mutations in the QSP motif of mRS1-Reg induced selective downregulation of phlorizin inhibited AMG uptake mediated by mSGLT1 (Gorboulev et al., 2012) versus sodium dependent uridine uptake mediated by mouse transporters CNT1 and CNT2 (Errasti-Murugarren et al., 2012) .
We provided evidence for the physiological relevance of RS1 dependent downregulation of transporter abundance in the plasma membrane using SGLT1 as example. SGLT1 is the most abundant transporter in the BBM of small intestine and is rate limiting for glucose absorption (Gorboulev et al., 2012; Vrhovac et al., 2014; Wisniewski et al., 2014) . After a glucose-rich meal the capacity of small intestine for glucose absorption is increased by rapid upregulation of SGLT1 abundance in the BBM (Gorboulev et al., 2012) . In the present report we show that RS1 is critically involved in this glucose dependent short-term upregulation of SGLT1. Between meals, when the glucose concentration in small intestine and enterocytes is low, RS1 downregulates the delivery of SGLT1 from the TGN to the plasma membrane (Fig. 9A) . However, after increase of glucose levels in This article has not been copyedited and formatted. The final version may differ from this version. the small intestine, RS1-mediated downregulation of SGLT1 delivery to the BBM is blunted (Fig. 9B ).
Under this condition glucose may bind to the RS1-Reg receptor protein (R (SGLT1) ) (or to a protein associated with the receptor) and may induce dissociation of RS1-Reg from the receptor protein. This may result in a disinhibition of receptor mediated increase of vesicle release from the TGN leading to upregulation of SGLT1 in the BBM (see scheme in Fig. 11 ).
The detection of a protein that steers glucose dependent upregulation of glucose absorption provides a new target for treatment of type 2 diabetes. If upregulation of SGLT1 in small intestine after glucose-rich meals is prevented, secretion of the antidiabetic enterohormone glucagon like peptide 1
(GLP-1) should be increased as observed after inhibition of SGLT1 and after impairment of glucose absorption by duodenal-jejunal bypass surgery (Jurowich et al., 2013; Powell et al., 2013) . Decreased We hope that our report will stimulate investigations on different exocytotic pathways that are addressed by RS1-Reg. This includes the identification of RS1-Reg receptor proteins that mediate regulation of individual transporters, the characterization of RS1-Reg modifications that address the different receptors, and the characterization of vesicle populations carrying different plasma membrane transporters. Because the described regulation implicates more complex selective sorting as has been described and expected (Anitei and Hoflack, 2011; Mayinger, 2011) , a detailed investigation concerning sorting of plasma membrane transporters at the TGN is warranted. In addition, the mechanism how vesicle release is steered by RS1-Reg and activated by RS1-Reg receptors must be This article has not been copyedited and formatted. The final version may differ from this version. of Ser20 in hRS1 (hRS1-Reg(S20E)) increased the affinity dramatically. B, after injection of AMG the affinity of hRS1-Reg(S20A) was decreased whereas the affinity of hRS1-Reg(S20E) was increased. C, mimicking phosphorylation of Ser19 in mRS1-Reg (mRS1-Reg(S19E)) increased the affinity dramatically. D, after injection of AMG the affinities of mRS1-Reg(S19A) and mRS1-Reg(S19E) were not changed significantly (see also . 30 minutes later the mice were sacrificed, the jejunum removed, and BBM vesicles were isolated. D and E, Rs1 +/+ and RS1 -/-mice fasted over night were sacrificed and the jejunum was removed, washed with PBS, and everted. The everted jejunum was incubated for 2 min in PBS without or with 2 mM AMG, and BBM vesicles were isolated. A and D, uptake of 100 µM AMG was measured in the absence or presence of 0.2 mM phlorizin, and phlorizin inhibited AMG uptake calculated. B and E, western blots of the BBM vesicles were stained with a specific antibody against SGLT1 and staining was quantified by densitometry. C, western blots of BBM vesicles were stained with antibody against GLUT2 and staining was quantified by densitometry. Mean values + SE are shown and the number of experiments is indicated in parenthesis.
Significances of differences were calculated by ANOVA with posthoc Tukey comparison. **p<0.01, ***p<0.001. . Effects of gavage of mice with mRS1-Reg(S19E) and mRS1-Reg(S19A) on phlorizin inhibitable AMG uptake and sodium dependent uridine uptake at low and high intracellular glucose.
Rs1
-/-or Rs1 +/+ mice were gavaged with mRS1-Reg(S19A) or mRS1-Reg(S19E) coupled to nanohydrogel (NG) or with unloaded NG (control). Three hours after gavage, phlorizin inhibited uptake of 10 µM AMG (A and D, low intracellular glucose), sodium dependent uptake of 1 µM uridine (B) or phlorizin inhibited uptake of 1 mM AMG (C and E, high intracellular glucose) into enterocytes of segments of everted jejunum was measured. After gavage with unloaded NG, phlorizin inhibited uptake of 10 µM AMG was 35% higher in Rs1 -/-mice compared to Rs1 +/+ mice (233 + 8.5 versus 173 + 11 pmol × cm -1 min -1 , means + SE, p<0.001 for difference) whereas phlorizin inhibited uptake of 1 mM AMG was 13% lower (18.9 + 0.8 versus 21.6 + 0.9 nmol × cm -1 min -1
, means + SE, p< 0.05 for difference). Sodium dependent uptake of 1 µM uridine in Rs1 -/-mice gavaged with unloaded NG was 55.7 + 2.1 pmol × cm -1 min -1 (mean + SE). A, B and C, in mRS1 -/-mice AMG uptake was downregulated by mRS1-Reg(S19E) whereas uridine uptake was down-regulated by mRS1-Reg(S19A). D and E, in mRs1 +/+ mice uptake of 1 mM AMG was down-regulated by mRS1-Reg(S19E) whereas uptake of 10 µM AMG was not altered. Uptake per 1 cm of jejunal segment is indicated. The numbers of employed animals are indicated in parenthesis.*p<0.05, **p<0.01, ***p<0.001, ANOVA with posthoc Tukey comparison.
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